-
3
-
-
67649649822
-
Overview of pathogenesis of systemic sclerosis
-
iii3-7
-
Abraham DJ, Krieg T, Distler J, Distler O. Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) 2009, 48(Suppl 3):iii3-7.
-
(2009)
Rheumatology (Oxford)
, vol.48
, Issue.SUPPL. 3
-
-
Abraham, D.J.1
Krieg, T.2
Distler, J.3
Distler, O.4
-
5
-
-
62849100599
-
High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy
-
10.1186/ar2634, 2688174, 19261182, German Network for Systemic Scleroderma Centers
-
Hunzelmann N, Moinzadeh P, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, Müller-Ladner U, Olski TM, Pfeiffer C, Riemekasten G, Schulze-Lohoff E, Sunderkoetter C, Weber M, German Network for Systemic Scleroderma Centers High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy. Arthritis Res Ther 2009, 11:R30. 10.1186/ar2634, 2688174, 19261182, German Network for Systemic Scleroderma Centers.
-
(2009)
Arthritis Res Ther
, vol.11
-
-
Hunzelmann, N.1
Moinzadeh, P.2
Genth, E.3
Krieg, T.4
Lehmacher, W.5
Melchers, I.6
Meurer, M.7
Müller-Ladner, U.8
Olski, T.M.9
Pfeiffer, C.10
Riemekasten, G.11
Schulze-Lohoff, E.12
Sunderkoetter, C.13
Weber, M.14
-
6
-
-
0028920576
-
Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic sclerosis
-
10.1002/art.1780380309, 7880189
-
White B, Bauer EA, Goldsmith LA. Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic sclerosis. Arthritis Rheum 1995, 38:351-360. 10.1002/art.1780380309, 7880189.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 351-360
-
-
White, B.1
Bauer, E.A.2
Goldsmith, L.A.3
-
7
-
-
0031684342
-
Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis
-
10.1002/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O, 9751093
-
Steen VD, Medsger TA. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 1998, 41:1613-1619. 10.1002/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O, 9751093.
-
(1998)
Arthritis Rheum
, vol.41
, pp. 1613-1619
-
-
Steen, V.D.1
Medsger, T.A.2
-
8
-
-
0033771114
-
Long-term outcomes of scleroderma renal crisis
-
Steen VD, Medsger TA. Long-term outcomes of scleroderma renal crisis. Ann Intern Med 2000, 133:600-603.
-
(2000)
Ann Intern Med
, vol.133
, pp. 600-603
-
-
Steen, V.D.1
Medsger, T.A.2
-
9
-
-
36249001195
-
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease
-
10.1164/rccm.200702-326OC, 2078679, 17717203
-
Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, Goldin J, Arriola E, Strange C, Bolster MB, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel D, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, et al. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med 2007, 176:1026-1034. 10.1164/rccm.200702-326OC, 2078679, 17717203.
-
(2007)
Am J Respir Crit Care Med
, vol.176
, pp. 1026-1034
-
-
Tashkin, D.P.1
Elashoff, R.2
Clements, P.J.3
Roth, M.D.4
Furst, D.E.5
Silver, R.M.6
Goldin, J.7
Arriola, E.8
Strange, C.9
Bolster, M.B.10
Seibold, J.R.11
Riley, D.J.12
Hsu, V.M.13
Varga, J.14
Schraufnagel, D.15
Theodore, A.16
Simms, R.17
Wise, R.18
Wigley, F.19
White, B.20
Steen, V.21
Read, C.22
Mayes, M.23
Parsley, E.24
Mubarak, K.25
Connolly, M.K.26
Golden, J.27
Olman, M.28
Fessler, B.29
Rothfield, N.30
more..
-
10
-
-
49949114547
-
Molecular subsets in the gene expression signatures of scleroderma skin
-
10.1371/journal.pone.0002696, 2481301, 18648520
-
Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, Connolly MK, Whitfield ML. Molecular subsets in the gene expression signatures of scleroderma skin. PLOS One 2008, 3:e2696. 10.1371/journal.pone.0002696, 2481301, 18648520.
-
(2008)
PLOS One
, vol.3
-
-
Milano, A.1
Pendergrass, S.A.2
Sargent, J.L.3
George, L.K.4
McCalmont, T.H.5
Connolly, M.K.6
Whitfield, M.L.7
-
11
-
-
79956122627
-
Platelet-derived serotonin links vascular disease and tissue fibrosis
-
10.1084/jem.20101629, 3092343, 21518801
-
Dees C, Akhmetshina A, Zerr P, Reich N, Palumbo K, Horn A, Jüngel A, Beyer C, Krönke G, Zwerina J, Reiter R, Alenina N, Maroteaux L, Gay S, Schett G, Distler O, Distler JH. Platelet-derived serotonin links vascular disease and tissue fibrosis. J Exp Med 2011, 208:961-972. 10.1084/jem.20101629, 3092343, 21518801.
-
(2011)
J Exp Med
, vol.208
, pp. 961-972
-
-
Dees, C.1
Akhmetshina, A.2
Zerr, P.3
Reich, N.4
Palumbo, K.5
Horn, A.6
Jüngel, A.7
Beyer, C.8
Krönke, G.9
Zwerina, J.10
Reiter, R.11
Alenina, N.12
Maroteaux, L.13
Gay, S.14
Schett, G.15
Distler, O.16
Distler, J.H.17
-
12
-
-
35348967491
-
Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis
-
10.1186/ar2187, 2072889, 17767741
-
Koch AE, Distler O. Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther 2007, 9(Suppl 2):S3. 10.1186/ar2187, 2072889, 17767741.
-
(2007)
Arthritis Res Ther
, vol.9
, Issue.SUPPL. 2
-
-
Koch, A.E.1
Distler, O.2
-
13
-
-
0018386836
-
Biogenic amines derived from tryptophan in systemic and cutaneous scleroderma
-
Stachów A, Jabłońska S, Skiendzielewska A. Biogenic amines derived from tryptophan in systemic and cutaneous scleroderma. Acta Derm Venereol 1979, 59:1-5.
-
(1979)
Acta Derm Venereol
, vol.59
, pp. 1-5
-
-
Stachów, A.1
Jabłońska, S.2
Skiendzielewska, A.3
-
14
-
-
0023886092
-
Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon
-
10.1016/0167-5273(88)90238-0, 3397197
-
Biondi ML, Marasini B, Bianchi E, and Agostoni A. Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon. Int J Cardiol 1988, 19:335-339. 10.1016/0167-5273(88)90238-0, 3397197.
-
(1988)
Int J Cardiol
, vol.19
, pp. 335-339
-
-
Biondi, M.L.1
Marasini, B.2
Bianchi, E.3
Agostoni, A.4
-
15
-
-
0029033224
-
Increased plasma serotonin in primary pulmonary hypertension
-
10.1016/S0002-9343(99)80156-9, 7653484
-
Hervé P, Launay JM, Scrobohaci ML, Brenot G, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, Drouet L. Increased plasma serotonin in primary pulmonary hypertension. Am J Med 1995, 99:249-254. 10.1016/S0002-9343(99)80156-9, 7653484.
-
(1995)
Am J Med
, vol.99
, pp. 249-254
-
-
Hervé, P.1
Launay, J.M.2
Scrobohaci, M.L.3
Brenot, G.4
Simonneau, G.5
Petitpretz, P.6
Poubeau, P.7
Cerrina, J.8
Duroux, P.9
Drouet, L.10
-
16
-
-
33847348491
-
Systemic sclerosis: a prototypic multisystem fibrotic disorder
-
10.1172/JCI31139, 1804347, 17332883
-
Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007, 117:557-567. 10.1172/JCI31139, 1804347, 17332883.
-
(2007)
J Clin Invest
, vol.117
, pp. 557-567
-
-
Varga, J.1
Abraham, D.2
-
17
-
-
0018328685
-
Cyproheptadine in anorexia nervosa
-
10.1192/bjp.134.1.67, 367480
-
Goldberg SC, Halmi KA, Eckert ED, Casper RC, Davis JM. Cyproheptadine in anorexia nervosa. Br J Psychiatry 1979, 134:67-70. 10.1192/bjp.134.1.67, 367480.
-
(1979)
Br J Psychiatry
, vol.134
, pp. 67-70
-
-
Goldberg, S.C.1
Halmi, K.A.2
Eckert, E.D.3
Casper, R.C.4
Davis, J.M.5
-
18
-
-
0029064303
-
The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors
-
10.1111/j.1476-5381.1995.tb14977.x, 1908489, 7582481
-
Bonhaus DW, Bach C, DeSouza A, Salazar FH, Matsuoka BD, Zuppan P, Chan HW, Eglen RM. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br J Pharmacol 1995, 115:622-628. 10.1111/j.1476-5381.1995.tb14977.x, 1908489, 7582481.
-
(1995)
Br J Pharmacol
, vol.115
, pp. 622-628
-
-
Bonhaus, D.W.1
Bach, C.2
DeSouza, A.3
Salazar, F.H.4
Matsuoka, B.D.5
Zuppan, P.6
Chan, H.W.7
Eglen, R.M.8
-
19
-
-
0034068805
-
Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B)receptors
-
10.1038/sj.bjp.0703341, 1572101, 10821800
-
Glusa E, Pertz HH. Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B)receptors. Br J Pharmacol 2000, 130:692-698. 10.1038/sj.bjp.0703341, 1572101, 10821800.
-
(2000)
Br J Pharmacol
, vol.130
, pp. 692-698
-
-
Glusa, E.1
Pertz, H.H.2
-
20
-
-
18144416218
-
Agonism at 5-HT2B receptors is not a class effect of the ergolines
-
10.1016/j.ejphar.2005.03.010, 15862804
-
Jähnichen S, Horowski R, Pertz HH. Agonism at 5-HT2B receptors is not a class effect of the ergolines. Eur J Pharmacol 2005, 513:225-228. 10.1016/j.ejphar.2005.03.010, 15862804.
-
(2005)
Eur J Pharmacol
, vol.513
, pp. 225-228
-
-
Jähnichen, S.1
Horowski, R.2
Pertz, H.H.3
-
21
-
-
77957668307
-
Animal models of systemic sclerosis: prospects and limitations
-
10.1002/art.27647, 20617524
-
Beyer C, Schett G, Distler O, Distler JH. Animal models of systemic sclerosis: prospects and limitations. Arthritis Rheum 2010, 62:2831-2844. 10.1002/art.27647, 20617524.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 2831-2844
-
-
Beyer, C.1
Schett, G.2
Distler, O.3
Distler, J.H.4
-
22
-
-
69949186412
-
Criteria to select molecular targets for anti-fibrotic therapy
-
v12-3
-
Distler JH, Distler O. Criteria to select molecular targets for anti-fibrotic therapy. Rheumatology 2008, 47(Suppl 5):v12-3.
-
(2008)
Rheumatology
, vol.47
, Issue.SUPPL. 5
-
-
Distler, J.H.1
Distler, O.2
-
23
-
-
9144236521
-
Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release
-
10.1016/S0092-8674(03)01014-6, 14697203
-
Walther DJ, Peter JU, Winter S, Höltje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G, Bader M. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 2003, 115:851-862. 10.1016/S0092-8674(03)01014-6, 14697203.
-
(2003)
Cell
, vol.115
, pp. 851-862
-
-
Walther, D.J.1
Peter, J.U.2
Winter, S.3
Höltje, M.4
Paulmann, N.5
Grohmann, M.6
Vowinckel, J.7
Alamo-Bethencourt, V.8
Wilhelm, C.S.9
Ahnert-Hilger, G.10
Bader, M.11
|